FOXQ1 and cancer: Previous studies suggest that FOXQ1 induction may be driven by various mitogenic signaling pathways, including Wnt/β-catenin, YAP/TAZ, and FGFR1/ERK2 signaling (8, 9, 10); however, it is unlikely that these observations can sufficiently account for the increase in FOXQ1 levels across different cancer types.